Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Hepatic arterial complications in liver transplant recipients treated withpretransplantation chemoembolization for hepatocellular carcinoma
Autore:
Richard, HM; Silberzweig, JE; Mitty, HA; Lou, WYW; Ahn, J; Cooper, JM;
Indirizzi:
Mt Sinai Hosp, Dept Radiol, Div Intervent Radiol, New York, NY 10029 USA Mt Sinai Hosp New York NY USA 10029 ervent Radiol, New York, NY 10029 USA Mt Sinai Hosp, Dept Biostat, New York, NY 10029 USA Mt Sinai Hosp New York NY USA 10029 Dept Biostat, New York, NY 10029 USA St Lukes Roosevelt Hosp Ctr, Dept Radiol, Div Intervent Radiol, New York, NY USA St Lukes Roosevelt Hosp Ctr New York NY USA ent Radiol, New York, NY USA Alexandria Hosp, INOVA, Div Intervent Radiol, Dept Radiol, Alexandria, VA USA Alexandria Hosp Alexandria VA USA adiol, Dept Radiol, Alexandria, VA USA
Titolo Testata:
RADIOLOGY
fascicolo: 3, volume: 214, anno: 2000,
pagine: 775 - 779
SICI:
0033-8419(200003)214:3<775:HACILT>2.0.ZU;2-S
Fonte:
ISI
Lingua:
ENG
Soggetto:
MITOMYCIN-C; CIRRHOTIC-PATIENTS; THROMBOSIS; ANGIOPLASTY; CHEMOTHERAPY; EMBOLIZATION; DIAGNOSIS; TOXICITY; TIME;
Keywords:
hepatic arteries, chemotherapeutic embolization; hepatic arteries, thrombosis; liver neoplasms, angiography; liver neoplasms, US; liver, transplantation; vasculitis;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
25
Recensione:
Indirizzi per estratti:
Indirizzo: Richard, HM Univ Maryland, Med Ctr, Dept Diagnost Imaging, Div Intervent Radiol, 22 S Greene St, Baltimore, MD 21201 USA Univ Maryland 22 S Greene StBaltimore MD USA 21201 21201 USA
Citazione:
H.M. Richard et al., "Hepatic arterial complications in liver transplant recipients treated withpretransplantation chemoembolization for hepatocellular carcinoma", RADIOLOGY, 214(3), 2000, pp. 775-779

Abstract

PURPOSE: To compare the prevalence of hepatic arterial complications in patients who underwent hepatic arterial chemoembolization for hepatocellular carcinomas before orthotopic liver transplantation with the prevalence of hepatic arterial complications in the total population of liver transplant recipients. MATERIALS AND METHODS: Forty-seven patients underwent selective hepatic arterial chemoinfusion with mitomycin C, doxorubicin hydrochloride, and cisplatin combined with embolization. The prevalence rates for hepatic arterial complications, including pseudoaneurysm, stenosis, anastomotic disruption, and thrombosis, were tabulated and compared with results in 1,154 patients who underwent orthotopic liver transplantation but not chemoembolization. RESULTS: Of the 47 patients who had undergone preoperative hepatic arterial chemotherapy, 13% developed hepatic arterial complications within a mean of 7 days after transplantation; an 8% prevalence of hepatic arterial thrombosis was observed. Of the 1,154 patients who underwent orthotopic liver transplantation but not chemotherapy, 6% developed hepatic arterial complications; a 5% prevalence of hepatic arterial thrombosis was, observed. There was no statistically significant difference in the prevalence rates for thrombosis and complications between the patients who underwent chemoembolization before orthotopic liver transplantation and those who did not. The mean interval between chemotherapy and orthotopic liver transplantation was 111 days (range, 3-428 days). CONCLUSION: Patients who undergo hepatic arterial chemotherapy are not at an increased risk of developing hepatic arterial thrombosis or other hepatic arterial complications after orthotopic liver transplantation.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/07/20 alle ore 06:35:42